AI assistant
Q32 Bio Inc. — Director's Dealing 2023
Aug 8, 2023
34891_dirs_2023-08-07_31921e45-b5f3-4d4b-bad8-e61847320c0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2023-08-03
Reporting Person: Jordan Julie (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Common Stock | M | 1548 | — | Acquired | 4318 | Direct |
| 2023-08-03 | Common Stock | S | 436 | $1.39 | Disposed | 3882 | Direct |
| 2023-08-03 | Common Stock | M | 387 | — | Acquired | 4269 | Direct |
| 2023-08-03 | Common Stock | S | 109 | $1.39 | Disposed | 4160 | Direct |
| 2023-08-03 | Common Stock | M | 4644 | — | Acquired | 8804 | Direct |
| 2023-08-03 | Common Stock | S | 1308 | $1.39 | Disposed | 7496 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-03 | Restricted Stock Units | $ | M | 1548 | Disposed | Common Stock (1548) | Direct | |
| 2023-08-03 | Restricted Stock Units | $ | M | 387 | Disposed | Common Stock (387) | Direct | |
| 2023-08-03 | Restricted Stock Units | $ | M | 4644 | Disposed | Common Stock (4644) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F2: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
F3: The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
F4: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.
F5: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited.